Critical Assessment of the Prospects of Quorum-Quenching Therapy for Staphylococcus aureus Infection
International Journal of Molecular Sciences · 16.02.2023 · 24 (4) · 4025
DOI: 10.3390/ijms24044025 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.02.2023. Verfasst von Michael Otto. Beteiligte Einrichtung: Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Allergy and Infectious Diseases, U.S. National Institutes of Health (NIH).
Abstract (Originalsprache)
Staphylococcus aureus is an important pathogen that causes a high number of infections and is one of the leading causes of death in hospitalized patients. Widespread antibiotic resistance such as in methicillin-resistant S. aureus (MRSA) has prompted research into potential anti-virulence-targeted approaches. Targeting the S. aureus accessory gene regulator (Agr) quorum-sensing system, a master regulator of virulence, is the most frequently proposed anti-virulence strategy for S. aureus. While much effort has been put into the discovery and screening for Agr inhibitory compounds, in vivo analysis of their efficacy in animal infection models is still rare and reveals various shortcomings and problems. These include (i) an almost exclusive focus on topical skin infection models, (ii) technical problems that leave doubt as to whether observed in vivo effects are due to quorum-quenching, and (iii) the discovery of counterproductive biofilm-increasing effects. Furthermore, potentially because of the latter, invasive S. aureus infection is associated with Agr dysfunctionality. Altogether, the potential of Agr inhibitory drugs is nowadays seen with low enthusiasm given the failure to provide sufficient in vivo evidence for their potential after more than two decades since the initiation of such efforts. However, current Agr inhibition-based probiotic approaches may lead to a new application of Agr inhibition strategies in preventing S. aureus infections by targeting colonization or for otherwise difficult-to-treat skin infections such as atopic dermatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathogen Molecular Genetics Section, Laboratory of Bacteriology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20814, USA.
Förderung
- National Institute of Allergy and Infectious Diseases
- U.S. National Institutes of Health (NIH)
Zitieren
APA
Otto, M. (2023). Critical Assessment of the Prospects of Quorum-Quenching Therapy for Staphylococcus aureus Infection. International Journal of Molecular Sciences, 24(4), 4025. https://doi.org/10.3390/ijms24044025
Vancouver
Otto M. Critical Assessment of the Prospects of Quorum-Quenching Therapy for Staphylococcus aureus Infection. International Journal of Molecular Sciences. 2023;24(4):4025. doi:10.3390/ijms24044025
BibTeX
@article{Otto2023,
author = {Otto, Michael},
title = {Critical Assessment of the Prospects of Quorum-Quenching Therapy for Staphylococcus aureus Infection},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {4025},
doi = {10.3390/ijms24044025}
}
EUVIMED